Back
Cal-Maine Foods 10K Form
Buy
53
CALM
Cal-Maine Foods
Last Price:
$100.51
Seasonality Move:
7.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-02 | 10Q | CALM/Cal-Maine Foods Quarterly |
2024-01-03 | 10Q | CALM/Cal-Maine Foods Quarterly |
2023-10-03 | 10Q | CALM/Cal-Maine Foods Quarterly |
2023-07-25 | 10K | CALM/Cal-Maine Foods Annual |
2023-03-28 | 10Q | CALM/Cal-Maine Foods Quarterly |
2022-12-28 | 10Q | CALM/Cal-Maine Foods Quarterly |
Receive CALM News And Ratings
See the #1 stock for the next 7 days that we like better than CALM
CALM Financial Statistics
Sales & Book Value
Annual Sales: | $2.3B |
---|---|
Cash Flow: | $162.6M |
Price / Cash Flow: | 12.93 |
Annual Sales: | $36.71 |
Price / Book: | 2.65 |
Profitability
EPS (TTM): | 5.69000 |
---|---|
Net Income (TTM): | $277.9M |
Gross Margin: | $541.6M |
Return on Equity: | 16.61% |
Return on Assets: | 13.7% |
Cal-Maine Foods Earnings Forecast
Key Cal-Maine Foods Financial Ratios
-
The Gross Profit Margin over the past 29 years for CALM is 23.28%.
-
The Selling, General & Administrative Expenses for CALM have been equal to 10.01% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 0.20% of Operating Income.
-
The Net Earning history of CALM is 11.94% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 14 years.
Cal-Maine Foods Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Food Products |
Sector: | Consumer Staples |
Current Symbol: | CALM |
CUSIP: | 128030 |
Website: | calmainefoods.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 5.45 |
Quick Ratio: | 4.28 |
Price-to-Earnings
Trailing P/E Ratio: | 18.08 |
---|---|
Forward P/E Ratio: | 29.48 |
CALM Technical Analysis vs Fundamental Analysis
Buy
53
Cal-Maine Foods (CALM)
is a Buy
Is Cal-Maine Foods a Buy or a Sell?
-
Cal-Maine Foods stock is rated a BuyThe current Cal-Maine Foods [CALM] share price is $102.89. The Score for CALM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.